Invention Grant
- Patent Title: Multispecific anti GM-CSF antibodies
-
Application No.: US15568325Application Date: 2015-04-29
-
Publication No.: US10526404B2Publication Date: 2020-01-07
- Inventor: Davide Corti , Antonio Lanzavecchia , Luca Piccoli
- Applicant: INSTITUTE FOR RESEARCH IN BIOMEDICINE
- Applicant Address: CH Bellinzona
- Assignee: INSTITUTE FOR RESEARCH IN BIOMEDICINE
- Current Assignee: INSTITUTE FOR RESEARCH IN BIOMEDICINE
- Current Assignee Address: CH Bellinzona
- Agency: Seed IP Law Group LLP
- International Application: PCT/EP2015/000879 WO 20150429
- International Announcement: WO2016/173605 WO 20161103
- Main IPC: C07K16/24
- IPC: C07K16/24 ; C07K16/46 ; A61K39/00

Abstract:
The present invention provides multispecific antibodies, and antigen binding fragments thereof, that potently neutralize a cytokine and that may thus be useful in the prevention and/or treatment of inflammatory and/or autoimmune diseases. In particular, the present invention provides a multispecific antibody, or an antigen binding fragment thereof, comprising at least two different domains specifically binding to at least two different, non-overlapping sites in a cytokine and an Fc moiety. The invention also relates to nucleic acids that encode such antibodies and antibody fragments and immortalized B cells and cultured plasma cells that produce such antibodies and antibody fragments. In addition, the invention relates to the use of the antibodies and antibody fragments of the invention in screening methods as well as in the diagnosis, prophylaxis and treatment of inflammatory and/or autoimmune diseases.
Public/Granted literature
- US20180142014A1 ULTRA-POTENT NEUTRALIZATION OF CYTOKINES BY MULTISPECIFIC ANTIBODIES AND USES THEREOF Public/Granted day:2018-05-24
Information query